Acorda Therapeutics, Inc. Total Assets
Acorda Therapeutics, Inc. had Total Assets of $81.58 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2024-05-14
- 2024-03-31: Assets $81.58M.
- 2023-12-31: Assets $108.53M.
- 2023-09-30: Assets $366.34M.
- 2023-06-30: Assets $364.70M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2024-03-31 | $81.58M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $108.53M 10-Q · filed 2024-05-14 | |
| 2023-09-30 | $366.34M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $364.70M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $374.91M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $395.60M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $393.34M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $406.31M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $424.14M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $455.47M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $466.09M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $491.50M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $584.05M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $632.68M 10-K · filed 2022-03-18 | |
| 2020-09-30 | $710.45M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $728.21M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $753.83M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $799.72M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $879.91M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.20B 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $1.23B 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $1.30B 10-K · filed 2020-02-28 | |
| 2018-09-30 | $1.31B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $1.25B 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $1.19B 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $1.20B 10-K · filed 2020-02-28 | |
| 2017-09-30 | $1.35B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.33B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $1.32B 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $1.34B 10-K/A · filed 2018-03-09 | |
| 2016-09-30 | $1.32B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $1.35B 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $1.21B 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $1.11B 10-K · filed 2017-02-27 | $1.12B 10-K · filed 2016-02-29 |
| 2015-09-30 | $1.10B 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $1.10B 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $1.10B 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $1.07B 10-K · filed 2016-02-29 | $1.08B 10-K · filed 2015-02-27 |
| 2014-09-30 | $972.77M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $943.32M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $611.89M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $607.13M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $586.65M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $575.91M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $565.42M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $565.33M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $410.45M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $403.05M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $386.05M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $379.49M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $351.10M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $336.10M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $336.21M 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $342.10M 10-K · filed 2012-02-28 | $342.10M 10-K · filed 2011-03-01 |
| 2010-09-30 | $331.42M 10-Q · filed 2010-11-09 | |
| 2010-06-30 | $295.99M 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $319.47M 10-K · filed 2011-03-01 |